Hemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS) following treatment with tisagenlecleucel

被引:22
作者
Maria Martin-Rojas, Reyes [1 ]
Gomez-Centurion, Ignacio [1 ,2 ]
Bailen, Rebeca [1 ,2 ]
Bastos, Mariana [1 ,2 ]
Diaz-Crespo, Francisco [2 ,3 ]
Carbonell, Diego [1 ,2 ]
Correa-Rocha, Rafael [2 ]
Pion, Marjorie [2 ]
Munoz, Cristina [1 ,2 ]
Sancho, Milagros [2 ,4 ]
Gomez Fernandez, Isabel [2 ,5 ]
Oarbeascoa, Gillen [1 ,2 ]
Perez-Corral, Ana [1 ,2 ]
Martinez-Laperche, Carolina [1 ,2 ]
Anguita, Javier [1 ,2 ]
Buno, Ismael [1 ,2 ,6 ,7 ]
Menarguez, Javier [2 ,3 ]
Luis Diez-Martin, Jose [1 ,2 ,7 ]
Kwon, Mi [1 ,2 ]
机构
[1] Hosp Gen Univ Gregorio Maranon, Dept Hematol, Doctor Esquerdo 46, Madrid 28007, Spain
[2] Gregorio Maranon Hlth Res Inst, Madrid, Spain
[3] Hosp Gen Univ Gregorio Maranon, Dept Pathol, Madrid, Spain
[4] Hosp Gen Univ Gregorio Maranon, Intens Care Unit, Madrid, Spain
[5] Hosp Gen Univ Gregorio Maranon, Dept Nucl Med, Madrid, Spain
[6] Hosp Gen Univ Gregorio Maranon, Genom Unit, Madrid, Spain
[7] Univ Complutense Madrid, Madrid, Spain
来源
CLINICAL CASE REPORTS | 2022年 / 10卷 / 01期
关键词
CAR T cells; hemophagocytic lymphohistiocytosis; macrophage activation syndrome; tisagenlecleucel; T-CELL THERAPY; MANAGEMENT; DIAGNOSIS; EMAPALUMAB; CHILDREN;
D O I
10.1002/ccr3.5209
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chimeric antigen receptor (CAR) T cell-related HLH/MAS is an unusual manifestation of severe cytokine release syndrome (CRS) with poor prognosis and a challenging diagnosis. The establishment of specific diagnosis criteria is essential, and the combination of several techniques for CAR T-cell follow-up, allows a more precise management of this complication.
引用
收藏
页数:6
相关论文
共 18 条
[1]   EMAPALUMAB (ANTI-INTERFERON-GAMMA MONOCLONAL ANTIBODY) IN PATIENTS WITH MACROPHAGE ACTIVATION SYNDROME (MAS) COMPLICATING SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA) [J].
De Benedetti, F. ;
Brogan, P. ;
Bracaglia, C. ;
Pardeo, M. ;
Marucci, G. ;
Sacco, E. ;
Eleftheriou, D. ;
Papadopoulou, C. ;
Grom, A. ;
Quartier, P. ;
Schneider, R. ;
Jacqmin, P. ;
Frederiksen, R. ;
Ballabio, M. ;
De Min, C. .
ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 :180-180
[2]   Development and Validation of the HScore, a Score for the Diagnosis of Reactive Hemophagocytic Syndrome [J].
Fardet, Laurence ;
Galicier, Lionel ;
Lambotte, Olivier ;
Marzac, Christophe ;
Aumont, Cedric ;
Chahwan, Doumit ;
Coppo, Paul ;
Hejblum, Gilles .
ARTHRITIS & RHEUMATOLOGY, 2014, 66 (09) :2613-2620
[3]   HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis [J].
Henter, Jan-Inge ;
Horne, AnnaCarin ;
Arico, Maurizio ;
Egeler, R. Maarten ;
Filipovich, Alexandra H. ;
Imashuku, Shinsaku ;
Ladisch, Stephan ;
McClain, Ken ;
Webb, David ;
Winiarski, Jacek ;
Janka, Gritta .
PEDIATRIC BLOOD & CANCER, 2007, 48 (02) :124-131
[4]   Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19 [J].
Kochenderfer, James N. ;
Wilson, Wyndham H. ;
Janik, John E. ;
Dudley, Mark E. ;
Stetler-Stevenson, Maryalice ;
Feldman, Steven A. ;
Maric, Irina ;
Raffeld, Mark ;
Nathan, Debbie-Ann N. ;
Lanier, Brock J. ;
Morgan, Richard A. ;
Rosenberg, Steven A. .
BLOOD, 2010, 116 (20) :4099-4102
[5]   Treatment of hemophagocytic lymphohistiocytosis in adults [J].
La Rosee, Paul .
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2015, :190-196
[6]   Current concepts in the diagnosis and management of cytokine release syndrome [J].
Lee, Daniel W. ;
Gardner, Rebecca ;
Porter, David L. ;
Louis, Chrystal U. ;
Ahmed, Nabil ;
Jensen, Michael ;
Grupp, Stephan A. ;
Mackall, Crystal L. .
BLOOD, 2014, 124 (02) :188-195
[7]   Consensus recommendations for the diagnosis and management of hemophagocytic lymphohistiocytosis associated with malignancies [J].
Lehmberg, Kai ;
Nichols, Kim E. ;
Henter, Jan-Inge ;
Girschikofsky, Michael ;
Greenwood, Tatiana ;
Jordan, Michael ;
Kumar, Ashish ;
Minkov, Milen ;
La Rosee, Paul ;
Weitzman, Sheila .
HAEMATOLOGICA, 2015, 100 (08) :997-1004
[8]   Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis [J].
Locatelli, F. ;
Jordan, M. B. ;
Allen, C. ;
Cesaro, S. ;
Rizzari, C. ;
Rao, A. ;
Degar, B. ;
Garrington, T. P. ;
Sevilla, J. ;
Putti, M. -C. ;
Fagioli, F. ;
Ahlmann, M. ;
Diaz, J. -L. Dapena ;
Henry, M. ;
De Benedetti, F. ;
Grom, A. ;
Lapeyre, G. ;
Jacqmin, P. ;
Ballabio, M. ;
de Min, C. .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (19) :1811-1822
[9]   Management of hemophagocytic lymphohistiocytosis (HLH) associated with chimeric antigen receptor T-cell (CAR-T) therapy using anti-cytokine therapy: an illustrative case and review of the literature [J].
Major, Ajay ;
Collins, Jennifer ;
Craney, Caroline ;
Heitman, Alisa K. ;
Bauer, Emily ;
Zerante, Elizabeth ;
Stock, Wendy ;
Bishop, Michael R. ;
Jasielec, Jagoda .
LEUKEMIA & LYMPHOMA, 2021, 62 (07) :1765-1769
[10]   Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia [J].
Maude, S. L. ;
Laetsch, T. W. ;
Buechner, J. ;
Rives, S. ;
Boyer, M. ;
Bittencourt, H. ;
Bader, P. ;
Verneris, M. R. ;
Stefanski, H. E. ;
Myers, G. D. ;
Qayed, M. ;
De Moerloose, B. ;
Hiramatsu, H. ;
Schlis, K. ;
Davis, K. L. ;
Martin, P. L. ;
Nemecek, E. R. ;
Yanik, G. A. ;
Peters, C. ;
Baruchel, A. ;
Boissel, N. ;
Mechinaud, F. ;
Balduzzi, A. ;
Krueger, J. ;
June, C. H. ;
Levine, B. L. ;
Wood, P. ;
Taran, T. ;
Leung, M. ;
Mueller, K. T. ;
Zhang, Y. ;
Sen, K. ;
Lebwohl, D. ;
Pulsipher, M. A. ;
Grupp, S. A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (05) :439-448